FIB-4 score as a predictor of mortality outcomes in individuals with metabolic dysfunction-associated steatotic liver disease with moderate alcohol consumption: a nationwide cohort study

被引：0
|
作者：
Aboona, Majd [1 ]
Danpanichkul, Pojsakorn [2 ]
Chen, Vincent [3 ]
Rangan, Pooja [1 ]
Kim, Donghee [4 ]
Alkhouri, Naim [5 ]
Noureddin, Mazen [6 ,7 ]
Arab, Juan Pablo [8 ,9 ,10 ]
Wijarnpreecha, Karn [1 ,11 ,12 ]
机构：
[1] Univ Arizona, Coll Med, Phoenix, AZ USA
[2] Chiang Mai Univ, Chiang Mai, Thailand
[3] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[4] Stanford Univ, Sch Med, Stanford, CA USA
[5] Arizona Liver Hlth, Chandler, AZ USA
[6] Houston Res Inst, Houston, TX USA
[7] Houston Methodist Hosp, Houston, TX USA
[8] Pontificia Univ Catolica Chile, Santiago, Chile
[9] Western Univ, London, ON, Canada
[10] London Hlth Sci Ctr, London, ON, Canada
[11] Banner Univ, Med Ctr, Phoenix, AZ USA
[12] Univ Arizona, Coll Med, BIO5 Inst, Phoenix, AZ USA
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-278
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [21] FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
    Avares-da-Silva, Mario Reis
    Vargas, Marcia da Silva
    Rabie, Soheyla Mohd Souza
    Jonko, Gabriella
    Riedel, Patricia Gabriela
    Longo, Larisse
    Goncalves, Marcelo Rodrigues
    Luft, Vivian Cristine
    Joveleviths, Dvora
    ANNALS OF HEPATOLOGY, 2025, 30 (01)
  • [22] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949
  • [23] Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
    Jeong, Seogsong
    Oh, Yun Hwan
    Ahn, Joseph C.
    Choi, Seulggie
    Park, Sun Jae
    Kim, Hye Jun
    Lee, Gyeongsil
    Son, Joung Sik
    Jang, Heejoon
    Lee, Dong Hyeon
    Sha, Meng
    Chen, Lei
    Kim, Won
    Park, Sang Min
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03)
  • [24] The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Shinomiya, Ryo
    Miyake, Takanori
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Kida, Yoshifumi
    Okada, Yasuyuki
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1587 - 1598
  • [25] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
    Kim, Gi-Ae
    Jeong, Seogsong
    Jang, Heejoon
    Lee, Dong Hyeon
    Joo, Sae Kyung
    Kim, Won
    LIVER CANCER, 2024, 13 (04) : 426 - 437
  • [26] Serum metabolic signatures and MetalnFF diagnostic score for mild and moderate metabolic dysfunction-associated steatotic liver disease
    Chen, Yang
    Wang, Yiran
    Shen, Tianjiao
    Wang, Nan
    Bai, Xiao
    Li, Qiyang
    Fang, Siyue
    He, Zhe
    Sun, Changhao
    Feng, Rennan
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2025, 260
  • [27] Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study (vol 152, 155789, 2024)
    Han, Eugene
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong -Soo
    Ahn, Sang Hoon
    Lee, Yong -ho
    Kim, Seung Up
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 154
  • [28] CAUSE-SPECIFIC MORTALITY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A NATIONWIDE POPULATION-BASED COHORT STUDY
    Wester, Axel
    Issa, Gabriel
    Shang, Ying
    Strandberg, Rickard
    Hagstrom, Hannes
    HEPATOLOGY, 2024, 80 : S884 - S885
  • [29] DIABETIC MICROVASCULAR COMPLICATIONS ARE ASSOCIATED WITH MORTALITY IN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND TYPE 2 DIABETES MELLITUS: A NATIONWIDE STUDY
    Yeo, Yee Hui
    Li, Jie
    Chen, Qianqian
    Ni, Wenjing
    Zhu, Yixuan
    Geng, Nan
    Jia, Leyao
    Rui, Fajuan
    Wu, Chao
    Shi, Junping
    Qi, Xiaolong
    Cheng, Susan
    Velazquez, Amanda
    Kwan, Alan
    Trivedi, Hirsh
    HEPATOLOGY, 2024, 80 : S919 - S920
  • [30] Creatinine as a predictor of clinical events in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Di Betto, G.
    Farina, A.
    Palumbo, P.
    Patrizi, B.
    Righetti, R.
    Ferrarini, S.
    Corradini, E.
    Pietrangelo, A.
    Buzzetti, E.
    DIGESTIVE AND LIVER DISEASE, 2025, 57 : S37 - S38
12345